NOT KNOWN FACTUAL STATEMENTS ABOUT CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT

medicines that are substrates of your CYP3A enzyme as They could become less efficient during treatment with JOURNAVX. Your healthcare provider might need to regulate the dose of the medication when starting off or stopping JOURNAVXPathophysiological changes inside the periphery and central nervous method cause peripheral and central sensitization,